Sign In
Buy QGEN
$36.45
+0.760 (+2.13%)
At Close: Jun 03, 2026
QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership
04:05pm, Wednesday, 18'th Jun 2025
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and GENCURIX, Inc. (KOSDAQ: 229000) today announced a new partnership to develop oncology assa
QGEN Stock Rises in After Market Following Partnership With Incyte
09:30am, Monday, 16'th Jun 2025
QIAGEN teams up with Incyte to develop NGS-based companion diagnostics for blood cancers.
VENLO, Netherlands & WILMINGTON, Del.--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) and Incyte (Nasdaq: INCY) today announced a new global collaboration t
Should You Add QIAGEN Stock to Your Portfolio for Now?
01:16pm, Friday, 13'th Jun 2025
QGEN rides on test menu growth, strategic partnerships, and strong solvency, despite macro and market headwinds.
Here's Why Qiagen (QGEN) is a Strong Momentum Stock
10:56am, Monday, 09'th Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?
12:36pm, Friday, 06'th Jun 2025
Qiagen (QGEN) reported earnings 30 days ago. What's next for the stock?
Tracer Biotechnologies Announces Strategic Partnership with QIAGEN to Advance Blood-Based MRD Testing for Solid Tumors
06:20pm, Thursday, 05'th Jun 2025
NEW YORK--(BUSINESS WIRE)--Tracer Biotechnologies, a leader in blood-based molecular diagnostics for cancer, is pleased to announce a strategic partnership with QIAGEN (NYSE: QGEN; Frankfurt Prime Sta
Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term
10:50am, Wednesday, 04'th Jun 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why Qiagen (QGEN) is a Strong Value Stock
10:46am, Tuesday, 03'rd Jun 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances
09:11am, Tuesday, 03'rd Jun 2025
QIAGEN expands the oncology portfolio with new MRD testing alliances, setting the stage for personalized cancer care and stock growth.
QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships
02:05pm, Monday, 02'nd Jun 2025
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN #QIAGEN--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the expansion of its oncology diagnostics portfolio with two strategic partner
Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma
01:00pm, Monday, 02'nd Jun 2025
BOULDER, Colo. , Jun 2, 2025 /PRNewswire/ -- Foresight Diagnostics, a leading diagnostics company specializing in ultra-sensitive minimal residual disease (MRD) detection, today announced a strategic,
QGEN Stock Might Gain Following New Partnership With ID Solutions
09:45am, Friday, 23'rd May 2025
QGEN teams up with ID Solutions to boost QIAcuity's reach in oncology dPCR assays, aiming to strengthen its cancer research leadership.
QIAGEN expands digital PCR oncology research portfolio through partnership with ID Solutions
04:05pm, Thursday, 22'nd May 2025
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a new commercial partnership and co-marketing agreement with ID Solutions, a French provider of
Here's Why Qiagen (QGEN) is a Strong Momentum Stock
10:56am, Friday, 16'th May 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
